Template:Increased bleeding DDX: Difference between revisions

No edit summary
No edit summary
 
(2 intermediate revisions by one other user not shown)
Line 5: Line 5:
*Nonfunctional
*Nonfunctional
**[[Aspirin]]
**[[Aspirin]]
**[[Von Willebrand Disease (vWD)]]
**[[Von Willebrand disease]]
 
====Factor Related====
====Factor Related====
*Acquired (Drug Related)
*Acquired (Drug Related)
**[[Warfarin (Coumadin)]]
**[[Warfarin (Coumadin)]]
**[[Unfractionated Heparin]]
**[[Unfractionated heparin]]
**[[Low Molecular Weight Heparin (Enoxaparin)]] (i.e. Lovenox)
**[[Low molecular weight heparin]] (i.e. [[enoxaparin]] (Lovenox), [[dalteparin]])
**Factor Xa Inhibitors (e.g. [[rivaroxaban]], [[apixaban]], [[fondaparinux]], [[edoxaban]])
**Direct thrombin inhibitors (e.g. [[dabigatran]], [[argatroban]], [[bivalirudin]])
*Illness induced
*Illness induced
**[[Vitamin K deficiency]]
**[[Vitamin K deficiency]]
**[[Disseminated Intravascular Coagulation (DIC)]]
**[[Disseminated Intravascular Coagulation (DIC)]]
**[[Liver disease induced coagulopathy]]
**[[Liver disease induced coagulopathy]]
**[[Renal disease induced coagulopathy]]
**[[Uremic bleeding syndrome]]
*Genetic
*Genetic
**[[Hemophilia]]
**[[Hemophilia]]
**[[Factor VIII inhibitor]]
**[[Factor VIII inhibitor]]
**[[Lupus anticoagulant]]
**[[Lupus anticoagulant]]

Latest revision as of 17:24, 19 September 2019